rs1047130

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001211.6(BUB1B):​c.1164G>A​(p.Ala388Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.292 in 1,613,594 control chromosomes in the GnomAD database, including 72,408 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A388A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.23 ( 4968 hom., cov: 32)
Exomes 𝑓: 0.30 ( 67440 hom. )

Consequence

BUB1B
NM_001211.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.553

Publications

27 publications found
Variant links:
Genes affected
BUB1B (HGNC:1149): (BUB1 mitotic checkpoint serine/threonine kinase B) This gene encodes a kinase involved in spindle checkpoint function. The protein has been localized to the kinetochore and plays a role in the inhibition of the anaphase-promoting complex/cyclosome (APC/C), delaying the onset of anaphase and ensuring proper chromosome segregation. Impaired spindle checkpoint function has been found in many forms of cancer. [provided by RefSeq, Jul 2008]
BUB1B Gene-Disease associations (from GenCC):
  • mosaic variegated aneuploidy syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • mosaic variegated aneuploidy syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 15-40196650-G-A is Benign according to our data. Variant chr15-40196650-G-A is described in ClinVar as Benign. ClinVar VariationId is 257632.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.553 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BUB1BNM_001211.6 linkc.1164G>A p.Ala388Ala synonymous_variant Exon 9 of 23 ENST00000287598.11 NP_001202.5 O60566-1
LOC107984763XR_001751506.2 linkn.218-16449C>T intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BUB1BENST00000287598.11 linkc.1164G>A p.Ala388Ala synonymous_variant Exon 9 of 23 1 NM_001211.6 ENSP00000287598.7 O60566-1
BUB1BENST00000412359.7 linkc.1206G>A p.Ala402Ala synonymous_variant Exon 9 of 23 2 ENSP00000398470.3 O60566-3

Frequencies

GnomAD3 genomes
AF:
0.230
AC:
34970
AN:
151956
Hom.:
4962
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0613
Gnomad AMI
AF:
0.490
Gnomad AMR
AF:
0.295
Gnomad ASJ
AF:
0.188
Gnomad EAS
AF:
0.147
Gnomad SAS
AF:
0.239
Gnomad FIN
AF:
0.279
Gnomad MID
AF:
0.201
Gnomad NFE
AF:
0.315
Gnomad OTH
AF:
0.224
GnomAD2 exomes
AF:
0.272
AC:
68292
AN:
251252
AF XY:
0.273
show subpopulations
Gnomad AFR exome
AF:
0.0594
Gnomad AMR exome
AF:
0.352
Gnomad ASJ exome
AF:
0.185
Gnomad EAS exome
AF:
0.146
Gnomad FIN exome
AF:
0.285
Gnomad NFE exome
AF:
0.313
Gnomad OTH exome
AF:
0.261
GnomAD4 exome
AF:
0.298
AC:
436060
AN:
1461518
Hom.:
67440
Cov.:
36
AF XY:
0.297
AC XY:
216066
AN XY:
727070
show subpopulations
African (AFR)
AF:
0.0514
AC:
1719
AN:
33472
American (AMR)
AF:
0.349
AC:
15624
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.183
AC:
4771
AN:
26128
East Asian (EAS)
AF:
0.170
AC:
6753
AN:
39688
South Asian (SAS)
AF:
0.244
AC:
21080
AN:
86254
European-Finnish (FIN)
AF:
0.286
AC:
15278
AN:
53416
Middle Eastern (MID)
AF:
0.190
AC:
1095
AN:
5768
European-Non Finnish (NFE)
AF:
0.318
AC:
353454
AN:
1111690
Other (OTH)
AF:
0.270
AC:
16286
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
16837
33673
50510
67346
84183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11336
22672
34008
45344
56680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.230
AC:
34985
AN:
152076
Hom.:
4968
Cov.:
32
AF XY:
0.229
AC XY:
17020
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.0612
AC:
2541
AN:
41516
American (AMR)
AF:
0.295
AC:
4506
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.188
AC:
651
AN:
3466
East Asian (EAS)
AF:
0.147
AC:
762
AN:
5180
South Asian (SAS)
AF:
0.241
AC:
1159
AN:
4814
European-Finnish (FIN)
AF:
0.279
AC:
2946
AN:
10548
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.315
AC:
21439
AN:
67964
Other (OTH)
AF:
0.224
AC:
473
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1284
2569
3853
5138
6422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
362
724
1086
1448
1810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.280
Hom.:
11548
Bravo
AF:
0.225
Asia WGS
AF:
0.168
AC:
586
AN:
3478
EpiCase
AF:
0.303
EpiControl
AF:
0.296

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 02, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mosaic variegated aneuploidy syndrome 1 Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Colorectal cancer Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Premature chromatid separation trait Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
9.7
DANN
Benign
0.50
PhyloP100
-0.55
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1047130; hg19: chr15-40488851; COSMIC: COSV55010434; COSMIC: COSV55010434; API